Operating Cash Flow
West Pharmaceutical Services Operating Cash Flow decreased by 64.2% to $89.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.5%, from $129.40M to $89.90M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 6.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $144.40M | $190.10M | $160.80M | $151.20M | $173.10M | $168.90M | $230.80M | $138.10M | $169.20M | $230.10M | $239.10M | $118.20M | $165.00M | $180.10M | $190.10M | $129.40M | $177.10M | $197.20M | $251.10M | $89.90M |
| QoQ Change | — | +31.6% | -15.4% | -6.0% | +14.5% | -2.4% | +36.6% | -40.2% | +22.5% | +36.0% | +3.9% | -50.6% | +39.6% | +9.2% | +5.6% | -31.9% | +36.9% | +11.3% | +27.3% | -64.2% |
| YoY Change | — | — | — | — | +19.9% | -11.2% | +43.5% | -8.7% | -2.3% | +36.2% | +3.6% | -14.4% | -2.5% | -21.7% | -20.5% | +9.5% | +7.3% | +9.5% | +32.1% | -30.5% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's operating cash flow?
- West Pharmaceutical Services (WST) reported operating cash flow of $89.90M in Q1 2026.
- How has West Pharmaceutical Services's operating cash flow changed year-over-year?
- West Pharmaceutical Services's operating cash flow decreased by 30.5% year-over-year, from $129.40M to $89.90M.
- What is the long-term trend for West Pharmaceutical Services's operating cash flow?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's operating cash flow has grown at a 6.6% compound annual growth rate (CAGR), from $584.00M to $754.80M.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.